PRME Stock-Based Compensation
Prime Medicine Inc · Stock-Based Compensation

PRME Stock-Based Compensation
Latest reported$4.87Mperiod ending
PRME Quarterly Stock-Based Comp ($156.00K → $4.87M)
Quarterly stock-based compensation
High-resolution chart · PNG
PRME stock-based compensation history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 4,865,000 | |
| 4,644,000 | |
| 4,515,000 | |
| 12,747,000 | |
| 6,325,000 | |
| 5,681,000 | |
| 5,941,000 | |
| 6,827,000 | |
| 8,091,000 | |
| 5,209,000 | |
| 4,429,000 | |
| 4,217,000 | |
| 3,583,000 | |
| 1,681,000 | |
| 2,574,000 | |
| 1,417,000 | |
| 1,345,000 | |
| 1,123,000 | |
| 1,107,000 | |
| 339,000 | |
| 0 | |
| 0 | |
| -278,000 | |
| 156,000 |